Sarcena, Judith L.
HRN: 07-60-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2022
CEFTRIAXONE 1G (VIAL)
06/21/2022
06/27/2022
IVTT
2g
Q24
Urinary Leukocytes And Pus Cells
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes